- Home
- MNPR vs PPIH Comparison
MNPR vs PPIH Comparison
Compare MNPR & PPIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- PPIH
- Stock Information
- Founded
- MNPR 2014
- PPIH 1993
- Country
- MNPR United States
- PPIH United States
- Employees
- MNPR N/A
- PPIH N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- PPIH Pollution Control Equipment
- Sector
- MNPR Health Care
- PPIH Industrials
- Exchange
- MNPR Nasdaq
- PPIH Nasdaq
- Market Cap
- MNPR 248.8M
- PPIH 217.1M
- IPO Year
- MNPR 2019
- PPIH N/A
- Fundamental
- Price
- MNPR $44.21
- PPIH $30.51
- Analyst Decision
- MNPR Strong Buy
- PPIH
- Analyst Count
- MNPR 10
- PPIH 0
- Target Price
- MNPR $66.56
- PPIH N/A
- AVG Volume (30 Days)
- MNPR 38.8K
- PPIH 125.8K
- Earning Date
- MNPR 11-07-2025
- PPIH 09-19-2025
- Dividend Yield
- MNPR N/A
- PPIH N/A
- EPS Growth
- MNPR N/A
- PPIH N/A
- EPS
- MNPR N/A
- PPIH 1.55
- Revenue
- MNPR N/A
- PPIH $170,810,000.00
- Revenue This Year
- MNPR N/A
- PPIH N/A
- Revenue Next Year
- MNPR N/A
- PPIH N/A
- P/E Ratio
- MNPR N/A
- PPIH $19.65
- Revenue Growth
- MNPR N/A
- PPIH 9.96
- 52 Week Low
- MNPR $2.29
- PPIH $8.81
- 52 Week High
- MNPR $54.30
- PPIH $32.90
- Technical
- Relative Strength Index (RSI)
- MNPR 65.29
- PPIH 60.11
- Support Level
- MNPR $32.77
- PPIH $28.26
- Resistance Level
- MNPR $36.49
- PPIH $32.44
- Average True Range (ATR)
- MNPR 2.93
- PPIH 2.04
- MACD
- MNPR 1.14
- PPIH 0.02
- Stochastic Oscillator
- MNPR 99.97
- PPIH 64.06
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About PPIH Perma-Pipe International Holdings Inc.
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.